Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#28 of 388

Yatin Suneja

Guggenheim · Equity Research Analyst
ProvisionalRating since 2022No new ratings since Jul 2025

Analyst rating accuracy & track record

Yatin Suneja is an equity research analyst at Guggenheim. Quantellect has scored 22 of their stock calls across 14 companies. Their picks beat their sector 52% of the time over the next 12 months, and their price targets were reached of the time within a year.

Win % vs sector
52%
PT Hit % (12mo)
Avg sector-excess
+6.4%
Scored calls
22
Tickers
14
Tier
Provisional

Track record

Quantellect has scored 22 of Yatin Suneja's stock calls across 14 companies, dating back to 2022. Their rated stocks beat their own sector 52% of the time over the next 12 months. On a typical call, a Suneja pick returned +6.4% more than its sector over the following year.

Of the scored calls, 22 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ABVXAbivax SA American Depositary Shares
Buy$101.00Jul 2025+67.6%Hit
LRMRLarimar Therapeutics Inc
Buy$26.00Jun 2025−3.8%Miss
LRMRLarimar Therapeutics Inc
Buy$26.00Jun 2025−4.3%Miss
ALMSAlumis Inc
Buy$18.00Jun 2025+495.1%Hit
CABACabaletta Bio Inc
Buy$25.00May 2025+61.0%Miss
CABACabaletta Bio Inc
Buy$25.00May 2025+52.1%Miss
PHATPhathom Pharmaceuticals Inc
Buy$12.00May 2025+392.2%Hit
PHATPhathom Pharmaceuticals Inc
BuyApr 2025+122.2%
CABACabaletta Bio Inc
Buy$23.00Apr 2025+111.9%Miss
IFRXInflaRx N.V.
Buy$10.00Mar 2025−27.9%Miss
ZURAZura Bio Limited Class A Ordinary Shares
Buy$15.00Mar 2025+343.4%Miss
LRMRLarimar Therapeutics Inc
Buy$26.00Mar 2025+105.2%Miss
ACETAdicet Bio Inc
Buy$7.00Mar 2025−54.6%Miss
IMVTImmunovant Inc
BuyMar 2025+16.1%
IMVTImmunovant Inc
BuyMar 2025+24.5%
IMVTImmunovant Inc
Buy$44.00Feb 2025+29.7%Miss
SRZNSurrozen Inc
Buy$45.00Jan 2025+20.7%Miss
SYRESpyre Therapeutics Inc.
Buy$65.00Oct 2024−28.7%Miss
ZBIOZenas BioPharma, Inc. Common Stock
Buy$45.00Oct 2024+55.5%Miss
QTTBQ32 Bio Inc
Buy$100.00Jun 2024−84.0%Miss
ABVXAbivax SA American Depositary Shares
Buy$50.00Apr 2024−53.4%Miss
RLMDRelmada Therapeutics Inc
Buy$60.00Sep 2022−92.9%Miss
Go to

Yatin Suneja: analyst track record FAQ

Is Yatin Suneja a good stock analyst?

Yes, by track record. Yatin Suneja ranks number 28 of 388 of the analysts Quantellect scores, with a Q Score of 69 out of 100. Past results do not guarantee future ones.

What is Yatin Suneja's win rate?

Yatin Suneja's win rate is 52%. Across 22 scored calls, their rated stocks beat their sector 52% of the time over the next 12 months. On a typical call they returned +6.4% more than the sector.

What stocks and sectors does Yatin Suneja cover?

Yatin Suneja covers 14 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Yatin Suneja's price targets accurate?

Yatin Suneja's price targets are reached within 12 months — of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Yatin Suneja's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Yatin Suneja rank among Wall Street analysts?

Yatin Suneja ranks number 28 of 388 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.